ARLINGTON, Va., Aug. 9, 2021 /PRNewswire/ — Sands Capital held a first and final closing of its second life sciences dedicated fund, Sands Capital Life Sciences Pulse Fund II, L.P. (“Pulse II”), raising $560 million. This close increases total Pulse Strategy assets under management to more than $950 million, including Sands Capital Life Sciences Pulse Fund, L.P. (“Pulse I”) and related vehicles. The team will continue investing with the same emphasis on private therapeutics, diagnostics, and life sciences tools businesses. The strategy’s mission is to help transform how diseases are defined, diagnosed, and treated.
{iframe}https://www.prnewswire.com/news-releases/sands-capital-closes-560-million-life-sciences-fund-301351109.html{/iframe}